Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
Go back to Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026| (NYSE: LCTX) | Delayed: 1.26 +0.05 (4.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.28 | P/E | N/A | |||
| Day Low | $1.22 | EPS | $ | |||
| Volume | 1,514,939 | |||||
| (NYSE: LCTX) | Delayed: 1.26 +0.05 (4.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.28 | P/E | N/A | |||
| Day Low | $1.22 | EPS | $ | |||
| Volume | 1,514,939 | |||||

